Artificial Intelligence vs. Evidence-Based Clinical Trials in Humans: A Paradigm Shift in Clinical Research
DOI:
https://doi.org/10.63501/xptwta38Keywords:
AI in Clinical Trials, AGI in Healthcare, Machine Learning Simulation, Digital Twin in MedicineAbstract
Prospective interventional clinical studies in humans remain the cornerstone of evidence-based medicine, guiding clinical decision-making and regulatory approvals. However, with the rapid advancement of Artificial Intelligence (AI) and the conceptual emergence of Artificial General Intelligence (AGI), the medical community is beginning to explore whether these technologies can augment or even replace traditional clinical trials. This manuscript critically examines the capabilities of AI and AGI in simulating, predicting, and evaluating clinical interventions. We discuss the methodological, ethical, and regulatory considerations of such a paradigm shift. While AI shows promise in retrospective analyses, clinical decision support, and trial optimization, replacing prospective interventional trials remains beyond current technological and ethical limits. Though theoretically more capable, AGI introduces concerns of explainability, bias propagation, and validation challenges. The future of clinical trials may lie in hybrid models that integrate AI with traditional methodologies, enhancing efficiency without compromising scientific rigor.
References
• Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016). Assessing the gold standard—lessons from the history of RCTs. The New England Journal of Medicine, 374(22), 2175–2181. https://doi.org/10.1056/NEJMms1604593
• Bruynseels, K., Santoni de Sio, F., & van den Hoven, J. (2018). Digital twins in health care: Ethical implications of an emerging engineering paradigm. Frontiers in Genetics, 9, 31. https://doi.org/10.3389/fgene.2018.00031
• Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., ... & Dean, J. (2019). A guide to deep learning in healthcare. Nature Medicine, 25(1), 24–29. https://doi.org/10.1038/s41591-018-0316-z
• FDA. (2021). Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. U.S. Food and Drug Administration. https://www.fda.gov/media/145022/download
• Goertzel, B., & Pennachin, C. (2007). Artificial general intelligence. Springer.
Holzinger, A., Biemann, C., Pattichis, C. S., & Kell, D. B. (2017). What do we need to build explainable AI systems for the medical domain? arXiv preprint arXiv:1712.09923.
• Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., & Denniston, A. K. (2021). Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nature Medicine, 26(9), 1364–1374. https://doi.org/10.1038/s41591-020-1034-x
• London, A. J. (2019). Artificial intelligence and black-box medical decisions: Accuracy versus explainability. Hastings Center Report, 49(1), 15–21. https://doi.org/10.1002/hast.973
• Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022). AI in health and medicine. Nature Medicine, 28, 31–38. https://doi.org/10.1038/s41591-021-01614-0
• Topol, E. (2019). Deep medicine: How artificial intelligence can make healthcare human again. Basic Books.
Downloads
Published
Issue
Section
License
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, provided appropriate credit is given to the author(s) and the source. To view a copy of this license, visit: https://creativecommons.org/licenses/by/4.0